Your browser doesn't support javascript.
loading
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
Feil, Katharina; Adrion, Christine; Teufel, Julian; Bösch, Sylvia; Claassen, Jens; Giordano, Ilaria; Hengel, Holger; Jacobi, Heike; Klockgether, Thomas; Klopstock, Thomas; Nachbauer, Wolfgang; Schöls, Ludger; Stendel, Claudia; Uslar, Ellen; van de Warrenburg, Bart; Berger, Ingrid; Naumann, Ivonne; Bayer, Otmar; Müller, Hans-Helge; Mansmann, Ulrich; Strupp, Michael.
Afiliação
  • Feil K; Department of Neurology with Friedrich-Baur-Institute, University Hospital, Munich, Germany. katharina.feil@med.uni-muenchen.de.
  • Adrion C; German Center for Vertigo and Balance Disorders (DSGZ), University Hospital, Munich, Germany. katharina.feil@med.uni-muenchen.de.
  • Teufel J; Department of Neurology and German Center for Vertigo and Balance Disorders, University Hospital, Campus Grosshadern, Marchioninistrasse 15, Munich, 81377, Germany. katharina.feil@med.uni-muenchen.de.
  • Bösch S; Institute for Medical Informatics, Biometry and Epidemiology (IBE), University Hospital, Munich, Germany.
  • Claassen J; Department of Neurology with Friedrich-Baur-Institute, University Hospital, Munich, Germany.
  • Giordano I; German Center for Vertigo and Balance Disorders (DSGZ), University Hospital, Munich, Germany.
  • Hengel H; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Jacobi H; Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Klockgether T; German Center for Neurodegenerative Diseases (DZNE), Center for Clinical Research, Bonn, Germany.
  • Klopstock T; Department of Neurology and Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany.
  • Nachbauer W; German Center for Neurodegenerative Diseases (DZNE), Center for Clinical Research, Bonn, Germany.
  • Schöls L; German Center for Neurodegenerative Diseases (DZNE), Center for Clinical Research, Bonn, Germany.
  • Stendel C; Department of Neurology with Friedrich-Baur-Institute, University Hospital, Munich, Germany.
  • Uslar E; German Center for Neurodegenerative Diseases (DZNE), Munich, 80336, Germany.
  • van de Warrenburg B; Munich Cluster for Systems Neurology (SyNergy), Munich, 80336, Germany.
  • Berger I; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Naumann I; Department of Neurology and Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany.
  • Bayer O; Department of Neurology with Friedrich-Baur-Institute, University Hospital, Munich, Germany.
  • Müller HH; German Center for Neurodegenerative Diseases (DZNE), Munich, 80336, Germany.
  • Mansmann U; Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Strupp M; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands.
BMC Neurol ; 17(1): 7, 2017 Jan 10.
Article em En | MEDLINE | ID: mdl-28068987
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Ataxia Cerebelar / Leucina Tipo de estudo: Clinical_trials / Guideline / Observational_studies Aspecto: Patient_preference Limite: Adult / Humans Idioma: En Revista: BMC Neurol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Ataxia Cerebelar / Leucina Tipo de estudo: Clinical_trials / Guideline / Observational_studies Aspecto: Patient_preference Limite: Adult / Humans Idioma: En Revista: BMC Neurol Ano de publicação: 2017 Tipo de documento: Article